Cancer in developing countries: opportunity and challenge
- PMID: 8492315
- DOI: 10.1093/jnci/85.11.862
Cancer in developing countries: opportunity and challenge
Abstract
Epidemiologic observations indicate that environment and lifestyle are the major determinants of the geographical patterns of cancer. The developing countries, which account for 75% of the world's population, have lower incidence rates of cancer compared with the industrialized nations but bear more than half the global cancer burden. Demographic trends resulting from economic progress (decreasing incidence of infectious diseases, population growth, aging, and urbanization), coupled with increased tobacco consumption and dietary changes, indicate that developing countries will bear a continually increasing proportion of the world's cancer burden and its accompanying demand for the provision of costly treatment programs. Yet the developing countries command only 5% of the world's economic resources, and health care programs are already fully extended and frequently inadequate. Thus, cancer control in the developing countries, including preemptive prevention of the anticipated increases in cancers presently more common in the industrialized nations (e.g., lung, breast, and colon), should include much greater emphasis on cancer prevention than is presently the case. But there is another perspective. The developing countries, with their dramatic contrasts in lifestyles and environments and equally diverse patterns of cancer, provide an unparalleled, and often neglected, opportunity for studies directed toward understanding the mechanisms of environmental carcinogenesis. Such an understanding should eventually lead to the development of novel intervention approaches. Unfortunately, cancer research is much more difficult to conduct in the developing countries because of the lack of population-based registries, poor communication and transportation systems, and deficiencies in infrastructure, financial support, and the training of health professionals. These difficulties could be overcome, to the benefit of all, if the extent of collaboration in cancer research between the developing and industrialized nations were to be greatly expanded.
Similar articles
-
The United Nations Conference on Population.Draper Fund Rep. 1984 Jun;(13):1-3. Draper Fund Rep. 1984. PMID: 12339629
-
The Changing Global Burden of Cancer: Transitions in Human Development and Implications for Cancer Prevention and Control.In: Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Cancer: Disease Control Priorities, Third Edition (Volume 3). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2015 Nov 1. Chapter 2. In: Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Cancer: Disease Control Priorities, Third Edition (Volume 3). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2015 Nov 1. Chapter 2. PMID: 26913347 Free Books & Documents. Review.
-
Cancer in the global health era: opportunities for the Middle East and Asia.Asia Pac J Public Health. 2010 Jul;22(3 Suppl):75S-82S. doi: 10.1177/1010539510372846. Asia Pac J Public Health. 2010. PMID: 20566537
-
The exploding worldwide cancer burden: the impact of cancer on women.Int J Gynecol Cancer. 2004 Jan-Feb;14(1):1-11. doi: 10.1111/j.1048-891x.2004.14178.x. Int J Gynecol Cancer. 2004. PMID: 14764024 Review.
-
The rising burden of cancer in the developing world.Ann Oncol. 2006 Jun;17 Suppl 8:viii15-viii23. doi: 10.1093/annonc/mdl983. Ann Oncol. 2006. PMID: 16801335 Review.
Cited by
-
Incidence patterns and review of Hodgkin lymphoma in the Republic of Armenia.Ecancermedicalscience. 2021 Nov 18;15:1319. doi: 10.3332/ecancer.2021.1319. eCollection 2021. Ecancermedicalscience. 2021. PMID: 35047070 Free PMC article.
-
Chitosan as possible inhibitory agents and delivery systems in leukemia.Cancer Cell Int. 2021 Oct 18;21(1):544. doi: 10.1186/s12935-021-02243-w. Cancer Cell Int. 2021. PMID: 34663339 Free PMC article. Review.
-
Ligand-Independent EGFR Activation by Anchorage-Stimulated Src Promotes Cancer Cell Proliferation and Cetuximab Resistance via ErbB3 Phosphorylation.Cancers (Basel). 2019 Oct 14;11(10):1552. doi: 10.3390/cancers11101552. Cancers (Basel). 2019. PMID: 31615015 Free PMC article.
-
A preliminary randomised controlled study of short-term Antrodia cinnamomea treatment combined with chemotherapy for patients with advanced cancer.BMC Complement Altern Med. 2016 Aug 26;16(1):322. doi: 10.1186/s12906-016-1312-9. BMC Complement Altern Med. 2016. PMID: 27565426 Free PMC article. Clinical Trial.
-
Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer.Oncotarget. 2015 Nov 17;6(36):38866-80. doi: 10.18632/oncotarget.5640. Oncotarget. 2015. PMID: 26462152 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources